NATIONAL HEALTH INVESTORS INC (NHI): Results of Operations and Financial Condition
NATIONAL HEALTH INVESTORS INC (NHI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991-q22026earningsrelease.htm EX-99.1 Document Exhibit 99.1 Contact: Todd M. Siefert, Chief Financial Officer Phone: (615) 890-9100 NHI Announces Second Quarter 2026 Results MURFREESBORO, Tenn. – (Monday, August 10, 2026) National Health Investors, Inc. (NYSE: NHI) an
How this was made
The 30-second read
Why it matters
Key tradable takeaways are the magnitude of SHOP NOI growth (about 188% YoY), the capital allocation event (sale of the NHC portfolio to reduce leverage), and the earnings bridge signals (EPS up strongly, normalized FFO slightly down, normalized FAD up). These can influence near-term valuation multiples and positioning for REIT income and growth investors.
Market read
This is a primary earnings release with quantified operating growth and a major portfolio sale narrative, likely to drive REIT-focused sentiment and positioning.
What to watch
Same-store SHOP results were slightly down, and interest income declined while depreciation and G&A rose due to acquisitions and CFO transition costs, which could pressure future normalized metrics.
Background
National Health Investors, Inc. filed an 8-K with its Q2 2026 results for the quarter ended June 30, 2026, including operating metrics for its Senior Housing Operating Portfolio (SHOP) and Real Estate Investments segment dispositions.
Ticker impact
NHI reported Q2 2026 results, including 45.6% YoY growth in diluted EPS to $1.15 and SHOP NOI up about 188% YoY.
Near-term bias upward if investors focus on SHOP NOI acceleration and balance-sheet deleveraging; offset risk if normalized FFO and same-store trends disappoint.
The article is a primary earnings release with multiple quantified metrics (EPS, FFO, FAD, SHOP NOI, dispositions, leverage reduction narrative). However, it lacks full balance-sheet/leverage numbers and forward guidance, limiting precision on magnitude and duration of impact.
Market effects
Reinforces the senior housing REIT narrative of growth via SHOP acquisitions and NOI expansion, while highlighting portfolio sales as a leverage-management tool.
No specific regional demand signal beyond company-wide SHOP portfolio expansion.
Limited global relevance; primarily US senior housing REIT fundamentals and capital allocation.
Counterpoint
Normalized FFO per diluted share fell 2.5% YoY, suggesting that headline EPS strength may be partly driven by dispositions and non-recurring items rather than core cash earnings momentum.
Key entities
- public_companyNational Health Investors, Inc.
NYSE-listed senior housing REIT reporting Q2 2026 results and capital allocation actions, including SHOP expansion and sale of the NHC portfolio.
- business_segmentSenior Housing Operating Portfolio (SHOP)
Operating portfolio whose NOI and same-store performance are highlighted as the core growth engine.
- transactionNHC portfolio sale
Sale of a large real estate portfolio described as reducing balance sheet leverage below target range.